NPPA fixed retail price of 41 formulations: June 2025

Last Updated on July 8, 2025 by The Health Master

NPPA

Download NPPA notification No. S.O. 2469(E) dt 03-06-2025, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 41 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 2469 (E) dt 03-06-2025 based on the decision of 133rd Authority meeting dated 29-05-2025.

The notification states as follows:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

A table is given below the article

Note:

(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules, including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

Sl. No.	Medicines	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Alginate Raft- Forming Oral Suspension	Each  5  ml  contains: Sodium Alginate IP 250 mg Sodium Bicarbonate IP 133.5 mg Calcium Carbonate IP 80 mg	1 ml	M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Apex Laboratories Pvt. Ltd.	0.93
2	Atorvastatin & Ezetimibe Tablets	Each film coated tablet contains: Atorvastatin Calcium IP equivalent to Atorvastatin 10mg Ezetimibe IP 10mg	1 Tablet	M/s Safetab Life Science/ M/s Ajanta Pharma Ltd.	19.66
3	Atorvastatin & Ezetimibe Tablets	Each film coated tablet contains: Atorvastatin Calcium IP equivalent to Atorvastatin 80 mg Ezetimibe IP 10mg	1 Tablet	M/s     Windlas            Biotech Ltd./ M/s    Zydus           Healthcare Ltd.	54.29
4	Ceftriaxone, Sulbactam & Disodium Edetate Powder for solution for Infusion	Each vial contains: Ceftriaxone Sodium IP eq. to Ceftriaxone 1000 mg Disodium Edetate IP 37 mg Sulbactam Sodium IP eq. Sulbactam 500 mg	1 vial	M/s BDR Pharma- ceuticals International Pvt. Ltd./ M/S Glenmark Pharma-ceuticals Ltd.	515.57
5	Cefuroxime & Potassium Clavulanate Tablets	Each film coated tablet contains: Cefuroxime Axetil IP eq. to Cefuroxime                                 500                                 mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg	1 Tablet	M/s Supermax Drugs & Pharmaceuticals Pvt. Ltd. / M/s Profic Organic Ltd.	60.62
6	Cholecalciferol Oral Drops	Each ml of Suspension contains: Vitamin D3 IP 800 IU	1 ml	M/s                             Stedman Pharmaceuticals Pvt. Ltd.	4.76
7	Clindamycin & Nicotinamide gel	Clindamycin Phosphate IP eq. to Clindamycin 1.00% w/w Nicotinamide IP 4.00% w/w	1 gm	M/s                              Skymap Pharmaceuticals         Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd.	7.24
8	Iron, Folic Acid & Cyanocobalamin Syrup	Each 5 ml contains: Ferric Ammonium Citrate IP 110 mg Folic Acid IP 1.5 mg Cyanocobalamin IP 15 mcg Sorbitol (70%) (Non- Crystallising)	1 ml	M/s East African (I) Overseas / M/s Mankind Prime Labs Pvt. Ltd.	0.23
9	Melatonin & Zolpidem Tartrate Tablets	Each film coated tablet contains: Melatonin BP 3 mg Zolpidem Tartrate IP 5 mg	1 Tablet	M/s Windlas Biotech Ltd./ M/s Ipca Laboratories Ltd.	6.62
10	Melatonin & Zolpidem Tartrate Tablets	Each film coated tablet contains: Melatonin BP 3 mg Zolpidem Tartrate IP 10 mg	1 Tablet	M/s Windlas Biotech Ltd./ M/s Ipca Laboratories Ltd.	8.73

11	Polmacoxib & Paracetamol Tablets	Each uncoated tablet contains: Polmacoxib IH 2 mg Paracetamol IP 325 mg	1 Tablet	M/s Hetero Labs Ltd./ M/s Zuventus Healthcare Ltd.	15.39
12	Empagliflozin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayered tablet contains: Empagliflozin 10mg Metformin Hydrochloride 1000mg (as extended release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd.	9.90
13	Empagliflozin & Metformin Hydrochloride Tablets	Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	18.10
14	Empagliflozin & Metformin Hydrochloride Tablets	Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Zydus Healthcare Ltd.	18.10
15	Empagliflozin & Metformin Hydrochloride Tablets	Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	19.01
16	Empagliflozin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg (as Extended release)	1 Tablet	M/s MSN Laboratories Pvt. Ltd.	17.86
17	Empagliflozin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayered tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (as extended release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd.	11.70
18	Empagliflozin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 25 mg Metformin Hydrochloride IP 1000 mg (as Extended release)	1 Tablet	M/s MSN Laboratories Pvt. Ltd.	18.75
19	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 10 mg Linagliptin 5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Zydus Healthcare Ltd.	29.08
20	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 10 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd.	29.08

21	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 10 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Glenmark Pharmaceuticals Ltd.	29.08
22	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 10 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd.	28.57
23	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 10 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd.	17.50
24	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 25 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Zydus Healthcare Ltd.	33.13
25	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 25 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd.	32.43
26	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated bilayer tablet contains: Empagliflozin 25 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Emcure Pharmaceuticals Ltd.	33.13
27	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 25 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Glenmark Pharmaceuticals Ltd.	33.13
28	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 25 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd.	30.36
29	Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets	Each film coated tablet contains: Empagliflozin 25 mg, Linagliptin 5 mg, Metformin Hydrochloride IP 1000 mg (as Extended Release)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd.	19.50
30	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s USV Private Ltd.	12.82

31	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Emcure Pharmaceuticals Ltd.	12.82
32	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Alkem Laboratories Ltd.	12.82
33	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Dr. Reddys Laboratories Ltd.	12.82
34	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Zydus Healthcare Ltd.	12.82
35	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s USV Private Ltd.	14.50
36	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Emcure Pharmaceuticals Ltd.	14.50
37	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Alkem Laboratories Ltd.	14.50
38	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Eris Lifesciences Ltd.	14.50
39	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Dr. Reddys Laboratories Ltd.	14.50
40	Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg	1 Tablet	M/s Exemed Pharmaceuticals/ M/s Zydus Healthcare Ltd.	14.50
41	Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup	Each 5 ml contains: Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg	1 ml	M/s Vapi Care Pharma Pvt. Ltd. / M/s Apex Laboratories Pvt. Ltd.	1.01

• IP 2026 released: Salient Features
  January 7, 2026
• Drug alert: 205 drug samples declared as NSQ in November 2025
  December 25, 2025
• FDA Haryana is Redefining Drug Safety and MSMEs Growth
  December 17, 2025
• 10th edition of IP for standards of drugs in India
  December 9, 2025
• QR Code mandatory at every Medical Store for ADR reporting
  November 26, 2025
• Landmark Seminar by FDA Haryana on Spurious drugs and NDPS Misuse
  November 25, 2025